Nuzenio

Therapeutix

Therapeutix news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 17 latest news signals 8 publisher sources 100/100 entity strength

Latest news

Ocular Therapeutix (NASDAQ:OCUL) Upgraded to "Hold" at Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 06:17:05 GMTOcular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 20:05:00 GMTOcular Therapeutix Options for New Hires Carry $8.40 Price - Stock TitanStock Titan · Fri, 07 Aug 2026 20:05:00 GMTHere's What Analysts Are Forecasting For Ocular Therapeutix, Inc. (NASDAQ:OCUL) After Its Second-Quarter Results - SahmSahm · Thu, 06 Aug 2026 07:00:00 GMTOcular Therapeutix's NDA Plans for Axpaxli in Wet AMD Remain on Track, RBC Says - marketscreener.commarketscreener.com · Tue, 04 Aug 2026 16:00:37 GMTChardan Capital Reiterates "Buy" Rating for Ocular Therapeutix (NASDAQ:OCUL) - MarketBeatMarketBeat · Tue, 04 Aug 2026 12:21:47 GMTOcular Therapeutix (OCUL) Stock Faces Axpaxli Hopes Against Deepening Losses - simplywall.stsimplywall.st · Tue, 04 Aug 2026 02:24:11 GMTSticking With This Ocular Therapeutix Price Target as Key Treatment Moves Forward - TheStreet ProTheStreet Pro · Mon, 03 Aug 2026 14:30:00 GMT

Timeline

Sat, 08 Aug 2026 06:17:05 GMTOcular Therapeutix (NASDAQ:OCUL) Upgraded to "Hold" at Wall Street Zen - MarketBeat
Fri, 07 Aug 2026 20:05:00 GMTOcular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Fri, 07 Aug 2026 20:05:00 GMTOcular Therapeutix Options for New Hires Carry $8.40 Price - Stock Titan
Thu, 06 Aug 2026 07:00:00 GMTHere's What Analysts Are Forecasting For Ocular Therapeutix, Inc. (NASDAQ:OCUL) After Its Second-Quarter Results - Sahm
Tue, 04 Aug 2026 16:00:37 GMTOcular Therapeutix's NDA Plans for Axpaxli in Wet AMD Remain on Track, RBC Says - marketscreener.com
Tue, 04 Aug 2026 12:21:47 GMTChardan Capital Reiterates "Buy" Rating for Ocular Therapeutix (NASDAQ:OCUL) - MarketBeat

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Therapeutix.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.